Hugo Schuil
Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort
Schuil, Hugo; Derks, Marloes; Liefers, Gerrit-Jan; Portielje, Johanneke; van de Velde, Cornelis; Syed, Binafsha; Green, Andrew; Ellis, Ian; Cheung, Kwok-Leung; Bastiaannet, Esther
Authors
Marloes Derks
Gerrit-Jan Liefers
Johanneke Portielje
Cornelis van de Velde
Binafsha Syed
Dr Andy Green ANDREW.GREEN@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Ian Ellis
Professor KWOK_LEUNG CHEUNG KWOK_LEUNG.CHEUNG@NOTTINGHAM.AC.UK
DEPUTY HEAD OF EDUCATION & DIRECTOR OF THE BMBS MEDICINE PROGRAMMES
Esther Bastiaannet
Abstract
Objective: Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort.
Materials and Methods: Women aged 70 years and older diagnosed with breast cancer after 1990 with a T0-T2 tumor stage and no evidence of metastatic disease were included from a population-based cohort in the Netherlands and a British hospital-based cohort in Nottingham. Main outcomes were proportions of local and systemic treatment, ten-year overall survival and ten-year relative survival for each cohort.
Results: 1439 patients from Nottingham and 2180 patients from the Netherlands were included. Median follow-up was 12.4 years (IQR 11.0–14.0) in the FOCUS cohort and 6.4 years (IQR 6.2–6.8) in the Nottingham cohort. British patients were more likely to receive primary endocrine therapy (50.0% vs 7.5%, P < 0.001), and less likely to be managed with mastectomy or breast-conserving surgery (47.8% vs 90.5%, P < 0.001). Ten-years overall survival was 39.4% (95% CI 37.4–41.6%) in the FOCUS cohort and 34.3% (95% CI 30.7–38.3) in the Nottingham cohort (adjusted HR 0.97, 95% CI 0.87–1.08, P = 0.559). Ten-year relative survival was 82.5% (95% CI 75.6–90.1) in the FOCUS cohort and 77.6% (95% CI 66.4–90.7) in the Nottingham cohort (adjusted relative excess risk 1.67, 95% CI 1.21–2.29, P = 0.002).
Conclusion: Patients in the Nottingham cohort were more likely to receive primary endocrine therapy and had worse relative survival compared to the Dutch cohort. These findings encourage further research to equalize survival rates of breast cancer throughout Europe.
Citation
Schuil, H., Derks, M., Liefers, G.-J., Portielje, J., van de Velde, C., Syed, B., Green, A., Ellis, I., Cheung, K.-L., & Bastiaannet, E. (in press). Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort. Journal of Geriatric Oncology, https://doi.org/10.1016/j.jgo.2018.05.004
Journal Article Type | Article |
---|---|
Acceptance Date | May 4, 2018 |
Online Publication Date | May 18, 2018 |
Deposit Date | Jul 17, 2018 |
Publicly Available Date | Jul 17, 2018 |
Journal | Journal of Geriatric Oncology |
Print ISSN | 1879-4068 |
Electronic ISSN | 1879-4068 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1016/j.jgo.2018.05.004 |
Keywords | breast cancer, geriatric oncology, age, treatment, mortality, surgical therapy |
Public URL | https://nottingham-repository.worktribe.com/output/933003 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1879406817302862?via%3Dihub |
Contract Date | Jul 17, 2018 |
Files
1-s2.0-S1879406817302862-main.pdf
(903 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Stromal lymphocytes are associated with upgrade of B3 breast lesions
(2024)
Journal Article
The characteristics and prognostic significance of histone H1 expression in breast cancer
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search